Trials / Unknown
UnknownNCT02854449
Tumor Response in Hypofractionated Radiotherapy
Biomarkers of Tumor Response in Hypofractionated Radiotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will follow-up different immune cell populations in the blood before, during and after high dose radiation therapy which should give new information of the efficacy of Local Hypofractionated Radiotherapy and a rationale for adjuvant immunotherapy.
Detailed description
* Patient information and collection of a signed informed consent form * Clinical data collection * Blood samples of 5 mL: 1. after registration, prior to the first fraction of radiotherapy 2. during radiotherapy sessions 3. one month, 3 months after the last radiotherapy session * Storage of the blood samples at ambient temperature * Transportation of the samples to the Institute of Biology of Lille (IBL) - CNRS UMR8161 for analysis * Destruction of the samples at the end of the analysis
Conditions
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2019-12-01
- Completion
- 2020-12-01
- First posted
- 2016-08-03
- Last updated
- 2018-04-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02854449. Inclusion in this directory is not an endorsement.